Citation Impact
Citing Papers
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
2001
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
Development of photocrosslinkable hyaluronic acid‐polyethylene glycol‐peptide composite hydrogels for soft tissue engineering
2004
Environmental sensing through focal adhesions
2008 Standout
Delayed graft function in kidney transplantation
2004 Standout
Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat
1998
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA
2002 StandoutNature
Hydrogels in Regenerative Medicine
2009 Standout
Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
2011 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The emerging role of lncRNAs in cancer
2015 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
2011
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers
2008
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
2014 Nature
Molecular Signaling in Bioengineered Tissue Microenvironments
2002
Hydrogels for biomedical applications
2002 Standout
Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA
2009
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
2016 Standout
Ulcerative colitis
2012 Standout
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
Semisynthetic resorbable materials from hyaluronan esterification
1998
Inflammatory Bowel Disease
2002 Standout
Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial
2006
3D bioprinting of tissues and organs
2014 Standout
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Differential role of selectins in experimental colitis
2001
A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis
2006
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
2004 Standout
Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice
2001
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering
2005 Standout
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
1999
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Non-coding RNAs in human disease
2011 Standout
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2′-O-methyl phosphodiester oligonucleotides in normal rats
2005
Inhibition of microRNA with antisense oligonucleotides
2007
Revealing the world of RNA interference
2004 StandoutNatureNobel
Self-assembly and applications of biomimetic and bioactive peptide-amphiphiles
2006
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense Oligonucleotides
1999
XBP1 Links ER Stress to Intestinal Inflammation and Confers Genetic Risk for Human Inflammatory Bowel Disease
2008 Standout
Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels
2013 Standout
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
2010
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
1996
Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease
2007
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pathogen Recognition and Innate Immunity
2006 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Fabrication of novel biomaterials through molecular self-assembly
2003 Standout
Anemia of Chronic Disease
2005 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Peptoid-containing collagen mimetics with cell binding activity
2000
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis
2004
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
Muscle-Specific Pten Deletion Protects against Insulin Resistance and Diabetes
2005 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Potential roles of antisense technology in cancer chemotherapy
2000
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
Polymer Brushes via Surface-Initiated Controlled Radical Polymerization: Synthesis, Characterization, Properties, and Applications
2009 Standout
Nucleic Acid Biotechnology
1999
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Collagen Structure and Stability
2009 Standout
Therapeutic effect of intracolonically administered nuclear factorκB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis
2000
A water-soluble metal–organic complex array as a multinuclear heterometallic peptide amphiphile that shows unconventional anion dependency in its self-assembly
2015 StandoutNobel
Adhesion of α5β1 receptors to biomimetic substrates constructed from peptide amphiphiles
2001
Specific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic Mice
2002
Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease☆☆☆
1998
Essential Role of Pten in Body Size Determination and Pancreatic β-Cell Homeostasis In Vivo
2006 StandoutNobel
Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response
2009 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action
2006
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
2008
Current Progress on aptamer-targeted Oligonucleotide Therapeutics
2013
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
The binding of phosphorothioate oligonucleotides to CdS nanoparticles
2003
Works of Kim Stecker being referenced
Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice
2000
In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration
1998
Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization
2003
Characterization of a hyaluronic acid-Arg-Gly-Asp peptide cell attachment matrix
1996
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
1997
An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice
1997